Empathy, Alexithymia, and Theory of Mind in Borderline Personality Disorder.

The Journal of Nervous and Mental Disease
Faruk KılıçDuru Kuzugüdenlioğlu

Abstract

The purpose of this research was to determine the differences in empathy, alexithymia features, and theory of mind between healthy controls and patients with borderline personality disorder (BPD). Thirty-five patients with BPD and 35 healthy controls were included in the study. To measure the clinical variables, the Empathy Quotient (EQ), Reading the Mind in the Eyes Test (RMET), Toronto Alexithymia Scale (TAS-20), Barratt Impulsivity Scale-11 (BIS-11), and Beck Depression Inventory (BDI) were applied. We found that the BPD group had significantly worse total RMET and neutral RMET scores than the control group. There were no differences in the EQ scores between the BPD and control groups. The patients with BPD were more alexithymic than the controls, and alexithymia and depression scores predicted BPD status. Patients with BPD who have difficulty identifying their own emotions tend to display deficits in perceptions of facial emotions, which, in turn, may lead to misperceptions of social signals and thus contribute to excessive emotional intensity and tension in social situations. The study results reveal that alexithymia and depression are important variables in predicting BPD traits.

References

Nov 1, 1988·Journal of Clinical Psychology·F ScoginD Hamblin
Jan 1, 1973·Psychotherapy and Psychosomatics·P E Sifneos
Apr 4, 1969·Science·P EkmanW V Friesen
Apr 1, 1994·Acta Psychiatrica Scandinavica·R MulliganP Giannakopoulos
Jan 1, 1994·Journal of Psychosomatic Research·R M BagbyJ D Parker
Nov 1, 1995·Journal of Clinical Psychology·J H PattonE S Barratt
Dec 1, 1996·Journal of Psychosomatic Research·H Berenbaum
Apr 1, 1997·The Journal of Nervous and Mental Disease·D LevineJ Hood
Sep 24, 1999·Developmental Psychology·J W Astington, J M Jenkins
Mar 31, 2001·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S Baron-CohenI Plumb
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Feb 10, 2004·Psychotherapy and Psychosomatics·Graeme J Taylor, R Michael Bagby
May 28, 2004·Journal of Autism and Developmental Disorders·Simon Baron-Cohen, Sally Wheelwright
Jul 2, 2004·The American Journal of Psychiatry·Hans Joergen GrabeHarald Juergen Freyberger
Sep 17, 2004·Issues in Mental Health Nursing·Ann R BlandShari Manning
Jul 5, 2005·Clinical Psychology Review·Eric A FertuckBarbara Stanley
Feb 16, 2006·The Journal of Nervous and Mental Disease·Carolyn Zittel ConklinDrew Westen
Oct 28, 2006·Comprehensive Psychiatry·Michael J MinzenbergSophia Vinogradov
Mar 10, 2009·Journal of Personality Disorders·Gregor DomesSabine C Herpertz
Jan 5, 2010·Psychiatry Investigation·Sang Soo SeoSung Hoon Jeong
May 18, 2010·Psychiatry Research·John S OgrodniczukAnthony S Joyce
Aug 27, 2011·Türk psikiyatri dergisi = Turkish journal of psychiatry·Ejder Akgün YıldırımErdem Onur Ozalmete
Oct 5, 2011·Psychotherapy and Psychosomatics·Gregor DomesSabine C Herpertz
Jan 28, 2012·Journal of Psychosomatic Research·Gwenolé LoasMaurice Corcos
May 26, 2012·Psychiatry and Clinical Neurosciences·Lisa SchillingCarsten Spitzer
Sep 28, 2012·Journal of Personality Disorders·Antonia S NewLarry J Siever
Mar 22, 2013·Journal of Personality Disorders·Natalie Dinsdale, Bernard J Crespi
Jul 15, 2015·Personality Disorders·Brian W Haas, Joshua D Miller
Jan 11, 2017·Journal of Personality Disorders·Vera FlasbeckMartin Brüne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.